Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03355157
Title A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study). (PADMA)
Acronym PADMA
Recruitment Completed
Gender both
Phase FDA approved
Variant Requirements No
Sponsors German Breast Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Agaplesion Markus Krankenhaus - Klinik für Gynäkologie und Geburtshilfe Frankfurt am Main 60431 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field